View Clinical Trial (Medical Research Study)
Free Venlafaxine Treatment for Marijuana Addiction and Depression - 1 - NCT00131456-10032(Clinical Trial 126597)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
New York |
|
State:
|
|
NY |
| Zip Code: |
|
10032 |
| Conditions: |
|
Depression - Marijuana Abuse |
| Purpose: |
|
The purpose of this study is to determine if Venlafaxine Extended Release (Ven-XR) is
effective in treating individuals with marijuana addiction and depression.
|
| Study summary: |
|
Given that depression and marijuana addiction often occur together, medications to treat
individuals diagnosed with both conditions may be effective. The purpose of this study is to
determine the effectiveness of Ven-XR in treating individuals diagnosed with depression and
marijuana addiction.
During this twelve-week, double-blind, placebo-controlled study, study visits will occur
twice each week. During study visits, participants will receive either placebo or medication
and provide a urine sample for drug screening. Blood tests will be collected each month and
women must take pregnancy tests each month. Throughout the study, all participants will
receive individualized psychotherapy sessions. At each study visit, participants will be
given $5 to cover transportation costs. |
| Criteria: |
|
Inclusion Criteria:
- Meets criteria for current marijuana addiction and reports marijuana as primary drug
of abuse
- Currently meets criteria for depression
- Clinically depressed for at least 3 months during a period of active marijuana use
Exclusion Criteria:
- Meets criteria for past manic or psychotic disorder, unless substance-related
- History of seizures
- History of allergic reaction to either Venlafaxine or Ven-XR
- Unstable medical conditions
- Physical dependence on any other drugs (excluding nicotine) that would require
medical detoxification
- Pregnant or breast-feeding |
|
|
|
| Study is available at: |
|
New York State Psychiatric Institute
New York, NY 10032
United States
Primary Contact:
Daniel J Brooks, M.A.
Phone: 212-740-3205
Secondary Contact:
Substance Abuse Treatment and Research Service
Phone: (212) 923-3031 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 21, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|